Ivim Health review

The care model is more substantial than a medication card

Ivim describes weekly app check-ins, provider-led dose adjustments, unlimited provider visits, functional health coaches and a dedicated patient-experience team. It also has a women’s hormone program and a traditional route for brand Wegovy or Zepbound. Those are specific service distinctions for someone who wants an ongoing program, rather than only a prescription and a delivery notification.

The decision is whether that support is worth the commitment attached to the selected program. Unlimited visits do not mean unlimited flexibility to leave, and a weekly check-in is not a guarantee that a particular dose will be prescribed. Ask what contact with the clinician actually looks like, how changes are reviewed and which parts of the broader program are included for your chosen treatment.

Add the required program fee before comparing prices

Its six-month compounded semaglutide program is advertised from $75 a month and tirzepatide from $133, each plus a $74.99 monthly program fee. The corresponding published starting totals are about $150 and $208 a month. Comparing the medication-only $75 or $133 with another service’s full treatment price would leave out a required recurring charge.

Ivim mentions one-, two-, four- and six-month program lengths, but it does not publish every standard-program price. The six-month figure therefore should not be presented as a freely cancelable month-to-month offer. Ask for the actual total of the proposed program and identify which payments are collected upfront, which recur and which charges remain due if treatment is paused.

Pausing is not the same as extending your purchase

The program FAQ says cancellation is not available once a program starts. The refund policy says prescribed medication is non-refundable regardless of usage, program duration or membership cancellation. It also states that inactive time does not extend the medication program period or create refund eligibility. This is a consequential distinction for someone who may need to interrupt treatment or travel during the purchase period.

Membership status matters to fulfillment as well: the policy says medication will not ship while membership is canceled or a payment fails. A buyer should therefore understand the medication commitment and the continuing care fee together. Before enrolling, ask how the program handles a clinical change, delayed use or an interruption the prescriber considers necessary, without assuming that an unused supply automatically generates credit.

The FDA letter concerns a specific labeling problem

FDA issued warning letter 721816 to Ivim Services LLC dba Ivim. The letter concerns product labels on Ivim’s site that suggested Ivim itself compounded the semaglutide and tirzepatide. The letter identifies Ivim’s own labeling and legal entity.

Ivim also footnotes some outcome claims to retrospective observational studies of its own patients. That is more specific than an unexplained success percentage, but observational results do not guarantee an individual outcome or prove superiority to another program. Women’s health marketing alone does not establish specialist expertise in postpartum or lactation care.

Decide on the commitment before selecting the lowest average

The microdose menu has its own two-, four- and six-month price table, with the same required program fee added. A microdose amount is not the price for a standard weight-loss course. Compounded treatment is also described as unavailable in some states without a complete published list, so confirm the actual treatment and address before planning around it.

Ivim is most relevant when a patient values its continuing contacts and can accept the selected program’s financial duration. Someone who needs an uncomplicated monthly exit has a clear reason to compare alternatives. Separate the clinical support, the medication, the program fee and the cancellation commitment; the six-month starting average is only one part of that choice.